Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dynavax ( (DVAX) ) has shared an announcement.
Dynavax Technologies Corporation has appointed two new directors, Lauren Silvernail and Emilio Emini, Ph.D., effective February 3, 2025. Lauren Silvernail will serve as a Class I Director until the 2025 Annual Meeting and chair the Audit Committee, while Emilio Emini will serve as a Class III Director until the 2027 Annual Meeting. Both will receive stock options and restricted stock units as part of their compensation, with Silvernail also receiving additional compensation for her role in the Audit Committee. The appointments follow the retirement and resignation of directors Peggy V. Phillips and Julie Eastland, and the Board’s decision to adjust the number of directors accordingly.
More about Dynavax
YTD Price Performance: 0.31%
Average Trading Volume: 2,050,671
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $1.7B
For a thorough assessment of DVAX stock, go to TipRanks’ Stock Analysis page.